Gf Fund Management Co. Ltd. Phathom Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,751 shares of PHAT stock, worth $17,895. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,751
Previous 1,436
21.94%
Holding current value
$17,895
Previous $11.7 Million
5.84%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHAT
# of Institutions
152Shares Held
66.6MCall Options Held
94KPut Options Held
55.5K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$103 Million3.99% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$76.3 Million12.73% of portfolio
-
Jennison Associates LLC7.04MShares$72 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA3.65MShares$37.3 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$35.7 Million27.15% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $400M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...